Follow POL on Twitter Paul Howard of the Manhattan Institute's Center for Medical Progress warns against the efforts of some in Congress to use a pending federal drug-regulation bill to curtail pre-emption and thus expand the scope of tort liability.
Pharma "litigation for all, and safety for none"
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Bridget Carroll Press Officer, Manhattan Institute bcarroll@manhattan-institute.org |
